PKG and PKC Are Down-Regulated during Cardiomyocyte Differentiation from Embryonic Stem Cells: Manipulation of These Pathways Enhances Cardiomyocyte Production

Table 1

Significance comparing treated groups to controls (for data points in Figure 3(a)) % of EBs beating.

DT-3 compared to controls
Day 12: $P<.02$	Day 13: $P<.002$	Day 14: $P<.008$	Day 15: $P<.005$	Day 16: $P<.002$	Day 17: $P<.002$
DT-3 + $\text{PKC}\zeta$ inhibitor compared to controls
Day 12: $P<.04$	Day 13: $P<.0005$	Day 14: $P<.001$	Day 15: $P<.0001$	Day 16: $P<.001$	Day 17: $P<.05$
DT-3 + PKCβ inhibitor compared to controls
Day 12: $P<.001$	Day 13: $P<.003$	Day 14: $P<.0008$	Day 15: $P<.001$	Day 16: $P<.001$	Day 17: $P<.003$